BLTE
BELITE BIO, INC
NASDAQ · Healthcare · Biotechnology · US
$170.96
+0.36%0
Insider buys (3m)
40
Insider sells (3m)
-$30.5M
Net value (3m)
+15.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 2,635 | $180 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 4,475 | $196 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 4,605 | $197 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 2,562 | $198 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 4,120 | $196 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 2,200 | $194 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 4,602 | $193 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 3,398 | $192 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 1,800 | $191 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 6,200 | $189 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 1,900 | $189 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 3,900 | $187 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 4,600 | $186 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 3,872 | $185 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 3,569 | $185 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 3,759 | $183 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 2,000 | $181 |
| Sep 9, 2026 | Chuang Hao-Yuan · director, officer: Chief Financial Officer | Sale | 1,633 | $180 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 2,700 | $198 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 8,752 | $197 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 6,058 | $197 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 6,090 | $196 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 2,400 | $194 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 8,111 | $193 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 4,209 | $193 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 11,080 | $191 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 600 | $190 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 8,955 | $189 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 3,045 | $188 |
| Sep 9, 2026 | Lin Yu-Hsin · director, officer: Chief Executive Officer | Sale | 6,200 | $187 |
Institutional positioning
13F filings over the trailing two quarters
New 50Increased 55Reduced 37Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Darwin Global Management, Ltd. | Increased | 3,077,219 | Aug 14, 2026 |
| DARWIN GLOBAL MANAGEMENT, LTD. | Increased | 3,057,412 | May 15, 2026 |
| Paradigm Biocapital Advisors LP | Increased | 1,232,877 | Aug 14, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | New Position | 1,114,784 | May 15, 2026 |
| UBS GROUP AG | Increased | 768,359 | May 5, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 715,332 | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 715,332 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 570,088 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 494,564 | Aug 14, 2026 |
| HOLOCENE ADVISORS, LP | Increased | 494,495 | May 15, 2026 |
| MAVERICK CAPITAL LTD | New Position | 396,311 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 390,829 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Reduced | 357,650 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Increased | 357,199 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 304,013 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 9, 2026